Inventor · disambiguated record
Dengming Xiao
Also filed as: XIAO DENGMING
42 granted patents·21 pending applications·565 citations·filing 2000–2025
98Inventor score
Files withARRAY BIOPHARMA INC18CV THERAPEUTICS INC8CENTAURUS BIOPHARMA CO LTD6MITCHELL IAN S6CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD5
Top patents by PatentIndex Score
63 records- 0197US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0296US6825349B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2002·Granted Nov 30, 2004·95 cites·31 claims
- 0395US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0495US7317017B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·22 cites·15 claims
- 0594US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 0694US6977300B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Dec 20, 2005·69 cites·25 claims
- 0793US7741331B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 22, 2010·16 cites·8 claims
- 0892US9725439B2Quinazoline derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Aug 8, 2017·13 cites·16 claims
- 0990US9926299B2Inhibitors of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2013·Granted Mar 27, 2018·33 cites·9 claims
- 1090US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 1190US7795269B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Sep 14, 2010·8 cites·14 claims
- 1289US8377937B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Feb 19, 2013·15 cites·37 claims
- 1388US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 1488US6525210B1Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactionsPENN STATE RES FOUND·Filed 2000·Granted Feb 25, 2003·17 cites·21 claims
- 1587US8329701B2Dihydrofuro pyrimidines as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Dec 11, 2012·12 cites·27 claims
- 1686US7304070B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·23 cites·36 claims
- 1785US9309211B2Arylalkene derivatives and use thereof as selective estrogen receptor modulatorsCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Apr 12, 2016·11 cites·6 claims
- 1884US8324224B2A2B adenosine receptor antagonistsKALLA RAO·Filed 2011·Granted Dec 4, 2012·5 cites·8 claims
- 1983US10561657B2Pyrrolopyrimidine compoundCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Feb 18, 2020·3 cites·19 claims
- 2082US9550781B2Kinase modulating compounds, compositions containing the same and use thereofCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Jan 24, 2017·9 cites·14 claims
- 2182US8618097B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsBENCSIK JOSEF·Filed 2008·Granted Dec 31, 2013·7 cites·48 claims
- 2281US10112922B2Inhibitor of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Oct 30, 2018·4 cites·8 claims
- 2381US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 2480US7238700B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Jul 3, 2007·11 cites·38 claims
- 2580US7105665B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Sep 12, 2006·12 cites·33 claims
- 2679US6770651B2A2B adenosine receptor antagonistsFiled 2002·Granted Aug 3, 2004·10 cites·41 claims
- 2777US8853216B2Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitorBENCSIK JOSEF·Filed 2009·Granted Oct 7, 2014·3 cites·5 claims
- 2877US2022226326A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2977US2025152588A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 3075US8846683B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Sep 30, 2014·1 cites·35 claims
- 3174US7696181B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2006·Granted Apr 13, 2010·1 cites·23 claims
- 3273US9708295B2Substituted 2-aminopyridine protein kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Jul 18, 2017·3 cites·17 claims
- 3373US9409886B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 9, 2016·2 cites·50 claims
- 3473US7144871B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2003·Granted Dec 5, 2006·5 cites·15 claims
- 3571US9303040B2Substituted piperazines as AKT inhibitorsMITCHELL IAN S·Filed 2007·Granted Apr 5, 2016·1 cites·32 claims
- 3671US8835434B2Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsBENCSIK JOSEF R·Filed 2009·Granted Sep 16, 2014·2 cites·2 claims
- 3771US2020345735A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3867US9981946B2Pyridine-substituted 2-aminopyridine protein kinase inhibitorsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 29, 2018·1 cites·20 claims
- 3967US6828271B2Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactionsPENN STATE RES FOUND·Filed 2002·Granted Dec 7, 2004·6 cites·33 claims
- 4064US9428508B22,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitorsXIAO DENGMING·Filed 2012·Granted Aug 30, 2016·2 cites·3 claims
- 4164US2014315887A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 4264US2018169099A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 4363US2009325896A1Partial and full agonists of a1 adenosine receptorsIBRAHIM PRABHA·Filed 2009·Application pending·0 cites
- 4462US2013123280A1A2b adenosine receptor antagonistsGILEAD SCIENCES INC·Filed 2012·Application pending·0 cites
- 4560US2016235754A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 4658US2014349996A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 4758US2011130362A1A2b adenosine receptor antagonistsGILEAD SCIENCES INC·Filed 2011·Application pending·0 cites
- 4856US2010222300A1A2B Adenosine Receptor AntagonistsGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
- 4956US2016152576A9Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 5055US2015197496A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →